FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Wesner, Katja; Hiemke, Christoph; Bergemann, Niels et al.
Therapeutic Reference Range forJOURNAL OF CLINICAL PSYCHIATRY. Bd. 84. H. 5. 2023
Winter, Yaroslav; Sandner, Katharina; Vieth, Thomas et al.
Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based StudyCNS DRUGS. Bd. 37. H. 10. 2023 S. 929-936
Gorodzeisky, A; Semyonov, M; Davidov, E et al.
Threats, Prejudice and Opposition to ImmigrationHochman, Oshrat (Hrsg). Immigration and Integration in Israel and Beyond. Bielefeld: Transcript Verlag 2023
Schmidt, A.; Kitzinger, R.; Poeschmann, A. et al.
Threshold concentrations for BPDE-induced cell death are characterised by altered DNA damage signalling and associated with unrepaired double-strand breaksNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 396. 2023 S. S33-S34
Linnemann, Birgit; Espinola-Klein, Christine
Thromboembolic disease - the angiologist's point of viewDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 148. H. 14. 2023 S. 890-898
Linnemann, Birgit; Espinola-Klein, Christine
Thromboembolic disease the angiologists point of viewDEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 148. H. 14. 2023 S. E98-E98
Klok, Frederikus A.; Pruszczyk, Piotr; Konstantinides, ?
Thrombolytic treatment of life-threatening pulmonary embolism in times of alteplase shortageEUROPEAN HEART JOURNAL. 2023
Mean, Marie; Breakey, Neal; Stalder, Odile et al.
Thrombophilia and outcomes of venous thromboembolism in older patientsRESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS. Bd. 7. H. 1. 2023
Ratziu, Vlad; Surabattula, Rambabu; Bugianesi, Elisabetta et al.
Thrombospondin-2 as a new biomarker for at risk NASH and advanced fibrosis in a large multicentric European cohortJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S652-S653
Schraner, Marissa; Tarasco, Erika; Stalder, Odile et al.
Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological Value of Prophylactic Plasma Treatment and Incidence of Acute Episodes in Patients Enrolled in the International Hereditary Thrombotic Thrombocytopenic Purpura RegistryBLOOD. Bd. 142. 2023